Federal Cannabis Law in the United States

The Controlled Substances Act

The Controlled Substances Act (CSA), passed in 1970, is the foundation of federal drug law in the United States. It places drugs into five schedules based on accepted medical use and abuse potential. Cannabis ("marihuana") was placed in Schedule I, the most restrictive category, meaning the federal government formally considers it to have a high potential for abuse and no accepted medical use ^[1][2].

Schedule I status has practical consequences beyond criminal penalties. It severely restricts research access, blocks cannabis businesses from normal banking and tax deductions under IRC § 280E, and makes cannabis use a deportable or inadmissibility issue under federal immigration law ^[3].

The CSA criminalizes manufacture, distribution, and possession. Simple possession of any amount is a federal misdemeanor for a first offense (21 U.S.C. § 844), though federal prosecutors rarely pursue small possession cases.

State legalization vs. federal prohibition

As of 2024, 24 states plus D.C. have legalized adult-use cannabis and 38 states have medical cannabis programs ^[4]. None of this changes federal law. Under the Supremacy Clause, federal law preempts conflicting state law, and the Supreme Court confirmed in Gonzales v. Raich (2005) that Congress has authority to criminalize cannabis even when grown and consumed entirely within a state that permits it ^[5].

What has changed is enforcement priority. Since 2014, Congress has annually passed the Rohrabacher–Farr amendment (now Joyce amendment), which forbids the Department of Justice from spending money to prosecute people complying with state medical cannabis laws ^[6]. This protection:

• Applies only to medical, not adult-use, programs
• Must be renewed each year as part of appropriations
• Does not change cannabis's underlying legal status

The earlier Cole Memorandum (2013) set DOJ enforcement priorities deferring to well-regulated state markets. Attorney General Jeff Sessions rescinded it in 2018, but in practice federal prosecutors have continued to focus on interstate trafficking, sales to minors, and links to other criminal activity rather than state-compliant operators ^[7].

Hemp and the 2018 Farm Bill

The Agriculture Improvement Act of 2018 ("2018 Farm Bill") removed hemp — defined as cannabis containing no more than 0.3% delta-9 THC by dry weight — from the CSA entirely ^[8]. This created the legal foundation for the explosive hemp-derived cannabinoid market, including CBD, delta-8 THC, HHC, and THCA products sold outside state cannabis programs.

The FDA still regulates hemp-derived ingredients in food, drugs, and supplements, and has stated that CBD cannot lawfully be added to food or sold as a dietary supplement under existing rules ^[9]. Many hemp-derived intoxicants exist in a gray zone the 2018 Farm Bill drafters did not anticipate, and several states have banned or restricted them independently. The 2024 Farm Bill reauthorization (delayed and being debated as of mid-2024) may close some of these loopholes.

The 2024 rescheduling proposal

In August 2023, the Department of Health and Human Services recommended that DEA move cannabis from Schedule I to Schedule III. In May 2024, the DOJ formally published a Notice of Proposed Rulemaking to do so ^[10]. As of the last-verified date on this article, the rule is not final. It must complete a public comment period and an administrative hearing process before taking effect.

If finalized, Schedule III status would:

• Eliminate the IRC § 280E tax penalty for state-legal cannabis businesses
• Significantly ease research restrictions
• Acknowledge accepted medical use

It would not:

• Legalize state adult-use programs under federal law (recreational sale would still violate the CSA)
• Permit interstate commerce in cannabis
• Resolve banking, immigration, or firearms issues automatically

Rescheduling is a meaningful but partial change. Full federal legalization would require an act of Congress.

Collateral federal consequences

Even where state law permits cannabis use, federal status creates downstream problems that catch people off guard:

• Firearms. ATF Form 4473 requires gun buyers to certify they are not unlawful users of a controlled substance. Cannabis users — even medical patients in legal states — must answer "yes" and are federally prohibited from purchasing firearms (18 U.S.C. § 922(g)(3)). The constitutionality of this is being litigated post-Bruen ^[11].
• Immigration. Cannabis use, admission of use, or even working in the legal cannabis industry can render non-citizens inadmissible or deportable. USCIS has explicitly confirmed this ^[3].
• Federal employment and security clearances. Federal agencies generally still disqualify cannabis users, though policies are gradually loosening for past use.
• Banking. Most federally chartered banks decline cannabis-business accounts because of money-laundering exposure. The SAFE Banking Act has passed the House multiple times but has not become law ^[12].
• Interstate travel. Carrying cannabis across state lines — even between two legal states — is federal trafficking. TSA's stated policy is to refer suspected cannabis to local law enforcement.

This article is not legal advice. Federal cannabis law changes frequently and applies differently depending on your state, immigration status, employment, and specific conduct. Consult a licensed attorney in your jurisdiction for any decision that depends on the legal status of cannabis.

Sources

How this page was made